Lilly’s Latest Leadership Shuffle Gives CSO Skovronsky Immunology Oversight

Moves Follow Recent Anti-Inflammatory Program Setbacks

 
• By Mandy Jackson
  
Man shuffling cards
Lilly's last leadership shuffle impacted neuroscience and oncology heads • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip